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Background: The Central Australian Indigenous population has a high incidence of Staphylococcus aureus
bacteremia (SAB) but little is known about the local molecular epidemiology.
Methods: Prospective observational study of bacteremic and nasal colonizing S.aureus isolates between June 2006
to June 2010. All isolates underwent single nucleotide polymorphism (SNP) genotyping and testing for the
presence of the Panton-Valentine Leucocidin (pvl) gene.
Results: Invasive isolates (n = 97) were predominantly ST93 (26.6 %) and pvl positive (54.3 %), which was associated
with skin and soft tissue infections (OR 4.35, 95 % CI 1.16, 16.31). Non-multiresistant MRSA accounted for 31.9 % of
bacteremic samples and showed a trend to being healthcare associated (OR 2.16, 95 % CI 0.86, 5.40). Non-invasive
isolates (n = 54) were rarely ST93 (1.9 %) or pvl positive (7.4 %).
Conclusions: In Central Australia, ST93 was the dominant S.aureus clone, and was frequently pvl positive and
associated with an aggressive clinical phenotype. Whether non-nasal carriage is more important with invasive
clones or whether colonization occurs only transiently remains to be elucidated.
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Staphylococcus aureus remains one of the most clinically
important bacteria. Approximately 60 % of humans are
transiently colonized and up to 30 % remain colonized
lifelong [1, 2]. Colonization conveys a significant risk of
invasive disease [1] including S.aureus bacteremia (SAB),
which continues to carry a significant risk of death [3].
Methicillin resistance in S.aureus is conveyed by the
mecA gene, found on mobile genetic elements known as
the staphylococcal chromosomal cassette (SCCmec) [2].
Initially, methicillin resistance was restricted to healthcare
associated organisms (HA-MRSA) amongst SCCmec
types I-III, but community acquired methicillin resistant
S.aureus (CA-MRSA) have recently emerged (SCCmec IV
or V). Such isolates often remain susceptible to non-beta-
lactam antibiotics [2], hence their description as non-
multiresistant (nm) MRSA. Although CA-MRSA were* Correspondence: sals7au@yahoo.com.au
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[4], strains have now emerged independently worldwide.
More recently, strains that express the Panton-Valentine
leukocidin (pvl) gene show a propensity for skin and soft
tissue infections (SSTI), especially furunculosis, and less
commonly necrotizing pneumonia. Whether pvl toxin dir-
ectly results in such presentations or is simply a virulence
marker remains unclear. Furthermore, pvl is not restricted
to MRSA [3].
S.aureus can be subtyped by multilocus sequence
typing (MLST), by SCCmec gene and by the presence of
pvl. Although different subtypes vary regionally, the
genetically unique and highly virulent ST93 now
predominates in Australia [5], a situation that is
analogous to the dominance of USA300 in the USA [2].
Central Australia is an isolated region inhabited by a
socially disadvantaged Indigenous population, mostly
residing in isolated remote communities and to a lesser
extent, in ‘town camps’ within the central town of Alice
Springs. The non-Indigenous population predominantlyle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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among the highest incidence rates of SAB reported,
160.7 per 100,000 persons with more than 50 % attribut-
able to SSTI and osteoarticular infections, approximately
20 % due to CA-MRSA [6], but the relative contribution
of different MLST types and pvl are unknown. Given
that methicillin resistance is common, efforts to isolate
MRSA colonized patients within the hospital is standard
practice. Whereas nasal colonization may play a role in
HA-MRSA infections [1], its relevance in CA-MRSA is
uncertain because strains often colonize sites other than
the nasopharynx [3].
This study aimed to describe the molecular epidemi-
ology of S.aureus in Central Australia and the rates of
pvl amongst; (i) strains found on routine nasal screening
and (ii) amongst bacteremic isolates.
Methods
We prospectively obtained all SAB isolates at Alice
Springs Hospital (ASH) between 1st June 2006 and 31st
January 2010 and separately collected all routinely
performed intensive care unit screening nasal swabs
performed between 1st May 2009 and 30th June 2010
where S.aureus was cultured. As per ASH admission cri-
teria, those aged less than 14 years old were classified as
pediatric.
Identification was initially by latex agglutination and
DNAse testing. Antibiotic susceptibility was determined
by Vitek (bioMerieux). MRSA was identified by cefoxitin
resistance and nmMRSA was defined as an organism
that was methicillin resistant but retained sensitivity to 3
or more non-beta-lactam antibiotics including gentamicin,
trimethoprim-sulfamethoxazole, doxycycline, erythro-
mycin, clindamycin, rifampicin, fusidic acid and cipro-
floxacin [4].
S.aureus isolates were grown on horse-blood agar
plates overnight at 37 °C. Five colonies from cultures
were suspended in 180 μl of 200 μg/ml Lysostaphin
enzyme solution, incubated at 37 °C for 30 minutes,
before DNA was extracted using a QIAGEN QIAamp
DNA Mini kit. Methicillin resistance was confirmed by
the presence of the mecA gene, as determined by PCR [7].
Staphylococcal sequence types were determined by
identifying sets of single nucleotide polymorphisms
(SNPs) that have been previously demonstrated to differ-
entiate Staphylococcus aureus strains into approximately
27 genotypes. These sequence types are consistent with
those identified by the more involved multilocus
sequence typing (MLST) and eBURST analysis [8], an
algorithm that displays the likely pattern of genomic
evolution of bacterial organisms [9]. “The “Minimum
SNPs” program [10] was used to calculate SNP sets,
from data held within the S.aureus MLST database,
optimized through maximization of the Simpson’s indexof diversity. SNP genotyping was performed using the
single tube kinetic PCR (STKP) method [11] that allows
for the examination of multiple targets using a generic
mix of primers, streamlined into a single tube reaction
[11]. The conventional “two-tube” interrogation was
applied to verify allele-specific real-time PCR cycle times
for S.aureus sequence type (ST) 1 [11] and for
ambiguous SNP results. Thereafter the STKP method
was employed to interrogate each S.aureus isolate.
MLST was performed on selected isolates for ST and
SNP profiling verification [12].
The ‘Queensland clone’, ST93, is a singleton by eburst
analysis. The ST93 SNP profile is shared by clonal
complexes ST59 and ST121 and other singletons. Mini-
mum SNPs was used to demonstrate one further SNP
(aroE252G) that when interrogated discriminated ST93
from all other known STs [11]. For ST-93 discrimination
the DNA template was quantified using UV spectropho-
tometry before use in PCR. This correlated with the
59,121,133 SNP profile termed “ST93 related” in this
study [11]. All isolates were tested for the presence of
the pvl gene [13].
For all bacteremic episodes, records were reviewed for
the source of infection, the presence of systemic inflam-
matory response syndrome (SIRS) criteria on admission,
intensive care (ICU) admission, comorbidities and survival
at 30 days and 12 months. Community acquisition of
infection was defined when the blood culture was drawn
within 48 hours of admission, nosocomial if after 48 hours,
and healthcare associated infection in those receiving
dialysis, those admitted for 2 or more days in the
preceding 90 days or nursing home residents.
Clinical and laboratory staffs were blinded to the results
of molecular studies and clinical details respectively.
Statistical analyses
Factors associated with pvl positive SAB strains were exam-
ined using univariable and multivariable logistic regression.
Candidate predictors were identified for inclusion in the
multivariable model using a combination of univariate per-
formance (p < 0.10) and clinical relevance. A Hosmer and
Lemeshow goodness-of-fit test was used to test the overall
fit of the final logistic models. For all analyses, p < 0.05 was
considered significant. All statistical analyses were per-
formed using Stata version 11 (StataCorp, College Station,
TX, USA). The study was approved by the Central
Australian Human Research Ethics Committee. Individual
informed consent was not required due to the observa-
tional nature of the study design.
Results
Ninety-seven bacteremic episodes (20 pediatric, 77 adult)
were identified in 94 individuals, 86 (91.4 %) of which
were Indigenous.
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On univariate analysis, MSSA was more likely community
acquired (OR 2.50; 95 % CI 1.00, 6.22). All MRSA identi-
fied were of a nmMRSA phenotype and there was a trend
for nmMRSA to be healthcare associated (OR 2.16; 95 %
CI 0.86, 5.40,). The presence of SIRS criteria on admission,
ICU admission, requirement for surgery and 30 day
mortality did not differ by resistance phenotype.
Pvl positive strains accounted for approximately half
of all episodes (54.3 %), regardless of resistance pheno-
type (Table 1). Pvl positive disease was associated with
community acquisition (OR 5.48; 95 % CI 2.06, 14.62)Table 1 Patient characteristics of SAB episodes according to pvl pos
pvl Negative
n (%)
Adult (36) Paed (7) Total (43)
Indigenous 30 (83.3 %) 7(100 %) 37 (86.1 %)
Age (range) 43.6 (0.42-95)
Male 22 (61.1 %) 3 (42.9 %) 25 (58.1 %)
RESIDENCE
Remote 17/35a (48.6 %) 5 (71.4 %) 22/42a (52.4 %)
Town Camp 6/35a (17.1 %) 1 (14.3 %) 7/42a (16.7 %)
Alice Springs 10/35a (28.6 %) 1 (14.3 %) 11/42a (26.2 %)
Nursing Home/Prison 2/35a (5.7 %) 0 (0 %) 2/42a (4.8 %)
STAPHYLOCOCCAL TYPING
MecA 9 (25.0 %) 2 (28.6 %) 11 (25.6 %)
ST93 1 (2.8 %) 0 (0 %) 2 (2.3 %)
ST93 or related 1 (2.8 %) 0 (0 %) 2 (2.3 %)
FOCUS OF INFECTION
SSTI 4 (11.1 %) 1 (14.3 %) 5 (11.6 %)
Osteoarticular 5 (13.9 %) 2 (28.6 %) 7 (16.3 %)
Pneumonia 3 (8.3 %) 1 (14.3 %) 4 (9.3 %)
Endocarditis 3 (8.3 %) 0 (0 %) 3 (7.0 %)
Line Related 9 (25.0 %) 0 (0 %) 9 (20.9 %)
ACQUISITION
Community Acquired 10 (27.8 %) 6 (85.7 %) 16 (37.2 %)
Healthcare Associated 25 (69.4 %) 1 (14.3 %) 26 (60.5 %)
Nosocomial 9 (25.0 %) 1 (14.3 %) 10 (23.3 %)
SEVERITY
SIRS 22 (61.1 %) 5 (71.4 %) 27 (62.8 %)
ICU admission 12 (33.3 %) 1 (14.3 %) 13 (30.2 %)
OUTCOME
Surgery 7 (19.4 %) 2 (28.6 %) 9 (20.9 %)
30 day Mortality 4 (11.1 %) 1 (14.3 %) 5 (11.6 %)
12 month Mortality 10 (27.8 %) 1 (14.3 %) 11 (25.6 %)
Note: ST93 related includes ST93, ST59 and ST121
Abbreviations: pvl Panton Valentine Leucocidin gene, SSTI skin and soft tissue infec
aThe residence for 1 adult patient was unable to be determinedand an SSTI focus in adults (OR 9.33; 95 % CI 2.37,
36.81). Among children there was a trend for pvl
positive SAB to result from osteoarticular infections (OR
12.50; 95 % CI 0.80, 194.35). Pvl positive strains were
also more likely to require surgical intervention (OR
6.93; 95 % CI 2.44, 19.66). Mortality did not differ be-
tween groups (Table 1).
Of the 54 nasal colonization isolates, 43 (79.6 %) were
from Indigenous patients and 30 (55.6 %) MRSA. Only
four isolates were pvl positive (7.4 %) and one was an
ST93 related strain. None of the colonized patients
developed bacteremia during duration of the study.itivity
pvl Positive Total (94) p-value
n (%) n (%)
Adult (39) Paed (12) Total (51)
38 (97.4 %) 11 (91.7 %) 49 (96.1 %) 86 (91.5 %) 0.082
39.5 (3-76) 0.378
25 (64.1 %) 8 (66.7 %) 33 (64.7 %) 58 (61.7 %) 0.514
24 (61.5 %) 11 (91.7 %) 35 (68.6 %) 57 (61.3 %) 0.109
11 (28.2 %) 0 (0 %) 11 (21.6 %) 18 (19.4 %) 0.552
3 (7.7 %) 1 (8.3 %) 4 (7.8 %) 15 (16.1 %) 0.017
1 (2.6 %) 0 (0 %) 1 (2.0 %) 3 (3.23 %) 0.447
13 (33.3 %) 4 (33.3 %) 17 (33.3 %) 28 (29.8 %) 0.413
20 (51.3 %) 4 (33.3 %) 24 (47.1 %) 25 (26.6 %) <0.001
30 (76.9 %) 9 (75.0 %) 39 (76.5 %) 40 (42.6 %) <0.001
21 (53.9 %) 1 (8.3 %) 22 (43.1 %) 27 (28.7 %) 0.001
5 (12.8 %) 10 (83.3 %) 15 (29.4 %) 22 (23.4 %) 0.134
6 (15.4 %) 0 (0 %) 6 (11.8 %) 10 (10.6 %) 0.700
0 (0 %) 0 (0 %) 0 (0 %) 3 (3.2 %) 0.055
2 (5.1 %) 0 (0 %) 2 (3.9 %) 11 (11.7 %) 0.011
27 (69.2 %) 12(100 %) 39 (76.5 %) 55 (58.5 %) <0.001
12 (30.8 %) 0 (0 %) 12 (23.5 %) 38 (40.4 %) <0.001
4 (10.3 %) 0 (0 %) 4 (7.8 %) 14 (14.9 %) 0.037
2 (74.4 %) 9 (75.0 %) 38 (74.5 %) 65 (69.2 %) 0.220
12 (30.8 %) 0 (0 %) 12 (23.5 %) 25 (26.6 %) 0.464
21 (53.9 %) 12 (100 %) 33 (64.7 %) 42 (44.7 %) <0.001
2 (5.1 %) 0 (0 %) 2 (3.9 %) 7 (7.5 %) 0. 156
5 (12.8 %) 0 (0 %) 5 (9.8 %) 16 (17.0 %) 0.055
tion, SIRS systemic inflammatory response syndrome, ICU intensive care unit
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pvl positive (OR 14.83; 95 % CI 4.27, 51.42) and
belong to ST93 (OR 9.42; 95 % CI 1.99, 44.57) or
ST93 related strains (OR 19.26; 95 % CI 3.81, 97.45)
(Table 1). Nasal colonizing organisms were moreFig. 1 Clonal complex (CC) distribution of bacteremic vs colonizing isolatelikely to be MRSA than bacteremic organisms (2.95;
95 % CI 1.43, 6.01).
The clonal complex (CC) distribution of bacteremic
and colonizing isolates is shown in Fig. 1. In both
cohorts, there was a broad range of strain types withins
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pvl negative MRSA group. CC1, CC5 and CC239 were
found in the pvl negative MRSA groups in both cohorts.
The pvl positive ST93 related strains (CC 59/121/133)
were the predominant strains found in MSSA bacteremia
(53.1 %) and the second most common in MRSA
bacteremia (23.3 %). Thirty-nine of 41 (95.1 %) bacteremic
ST93 related isolates were pvl positive.
On multivariate regression, an identifiable focus of in-
fection (OR 7.13; 95 % CI 1.28, 39.60), SSTI (OR 4.35;
95 % CI 1.16, 16.31) and community acquisition (OR
5.15; 95 % CI 1.85, 14.39) predicted pvl positive disease.
Living in urban Alice Springs was associated with a lower
chance of infection with a pvl positive strain compared
with remote residence (OR 0.19; 95 % CI 0.04, 0.82).
Discussion
Even within a geographically isolated continent, such as
Australia, S.aureus exhibits remarkable variability in
resistance patterns, virulence and epidemiology [2]. In
Central Australia, we found a diverse range of MSSA se-
quence types, however, ST93 was clearly dominant and
was strongly associated with pvl positivity, which was a
risk factor for bacteremia following SSTI.
These findings are consistent with the aggressive clinical
phenotype of ST93 and with recent Australian trends [14].
ST93 nmMRSA are frequently pvl positive, but recent
research increasingly suggests that other virulence factors
(alpha-hemolysin (Hla) exotoxin and alpha type phenol
soluble modulins (α-PSMs)) may explain the increased
virulence of ST93 staphylococcal infections [14]. In par-
ticular, over-expression of Hla - perhaps due to mutations
in the regulatory gene agr and positive regulation by the
aryK gene – may explain much of ST93 virulence [15].
ST93 CA-MRSA appears to be unique to Australia [2],
although ST93 MSSA were present prior to their MRSA
counterpart’s discovery. The coexistence of MSSA and
MRSA ST93, with diversity even within the sequence
type, has led to suggestions that the increasing rates of
ST93 is not simply the result of clonal expansion of a
single strain but rather perhaps by multiple different
independent acquisitions of SCCmec in different ST93-
MSSA strains [5, 16].
Similar to national trends, there is an increasing preva-
lence of CA-MRSA in Central Australia, 32 % in this
study compared with 20 % earlier in the same decade
[6].Reflecting trends elsewhere in Australia [17] and in
the USA [18], CA-MRSA in Central Australia appears to
be associated with healthcare contact.
Although resistance phenotype was not a virulence
marker, pvl was associated with distinct clinical presen-
tations. Among adults, pvl positive strains more often
caused SSTI and tended to be associated with osteoar-
ticular infections in children [3]. Reflecting thepropensity for pvl positive strains to cause local tissue
destruction [3], these strains were also more likely to
require surgical intervention. Consistent with other
studies, we found very few (10) pneumonic presenta-
tions, even in the setting of pvl [3]. Overall, thirty-day
mortality was lower than expected, probably attribut-
able to the surgical removal of the infective focus in
the large number of SSTIs.
Sequence types of colonizing strains were similar for pvl
negative MSSA and MRSA. However, very few pvl positive
strains were found and only one ST93 isolate colonized
the nasopharynx. The relative lack of pvl positive
colonization has been reported previously [3, 19]. The
different spectrum of colonizing to bacteremic strains
questions whether individuals with nasal MRSA are at risk
of invasive disease in our setting. Infection control strat-
egies have relied on nasopharyngeal carriage as the
principal reservoir for MRSA and colonization results in
an increased infection risk [1]. However nmMRSA is
known to colonize non-nasal sites including the axilla,
groin and perineum and this is perhaps even more likely
with pvl positive strains [3]. Apparent differences in the
ecology of invasive and colonizing strains suggests that
relying on nasal screening for hospital infection control
measures will have limited success in Central Australia.
Whether pvl positive organisms preferentially colonize
non-nasal sites or are so highly virulent that they rapidly
cause clinical infection requires further study.
Interpretation of colonization data is limited by poten-
tial selection bias because nasal MRSA screening typic-
ally occurs for patients admitted to intensive care.
Consequently, the number of subjects for whom S.aur-
eus colonization was determined was low. Moreover, as
no colonized patients developed bacteremia, we cannot
determine whether virulent Staphylococci also colonized
the nasopharynx of clinically infected individuals.
Conclusions
Our study further describes the expansion of nmMRSA,
and the clinical impact of pvl positive S.aureus,
particularly ST93, within an Indigenous population.
The well documented rates of overcrowding, poor
housing and poor access to hygiene infrastructure in
Indigenous communities in Central Australia [20] are
the perfect conditions to facilitate transmission of
virulent S.aureus clones [21] and will likely contribute
to increasing rates of nmMRSA and pvl associated dis-
ease in the future. The discrepancies in staphylococcal
clones involved in bacteremia versus colonization
warrant further investigation. Whether non-nasal
carriage is more relevant or whether colonization with
invasive clones occurs only transiently remains to be
elucidated, but may impact on infection control prac-
tices in similar populations.
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